Open AccessFixed-dose combination products and unintended drug interactions: urgent need for pharmacogenetic evaluation
Author(s) -
Jorge Ducongé,
Gualberto Ruaño
Publication year - 2015
Publication title -
pharmacogenomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.541
H-Index - 91
eISSN - 1744-8042
pISSN - 1462-2416
DOI - 10.2217/pgs.15.123
Subject(s) - pharmacogenomics , pharmacogenetics , biology , drug , cyp2c19 , pharmacology , drug metabolism , prodrug , computational biology , cyp2c9 , drug development , irinotecan , cytochrome p450 , genetics , cancer , genotype , enzyme , biochemistry , gene , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom